Point Sur Investors

Investing in Innovation


Our firm is managed by a small group of executives with a track record of managing biotech businesses through the drug discovery and development process. We leverage our in-house knowledge and expertise in life sciences to provide a differentiated investment approach.



Managing Member

Prior to forming the General Partner, from June 2013 through October 2015, Tom managed Investor Relations at Pharmacyclics Inc., where he helped grow the company from a market cap of $6.74B to over $21B, which included the execution of one of the largest biotech acquisitions to date.  Prior to Pharmacyclics, Inc., Tom spent 6 years as a medicinal chemist at Gilead Sciences Inc. engaging in novel drug design and drug development for HCV polymerase and protease inhibitors. Tom holds an M.B.A. from the University of California Los Angeles (2012) and a Master's degree in Organic Chemistry from the University of California Santa Barbara (2007).  As a research scientist, Thomas Butler has been awarded numerous patents in the U.S. and internationally, as well as published in top academic journals such as the American Chemical Society Journal of Medicinal Chemistry.



Managing Member

Ramses most recently served as the Executive Vice President of Corporate Affairs for Pharmacyclics, Inc. At Pharmacyclics, he helped grow the company from approximately 40 employees with a market cap of $40M in 2009 to 650 employees and a market cap of $21B in 2015, when it merged with AbbVie, Inc. Ramses was involved in the operational expansion of the company and oversaw various departments during the growth phase including Finance, HR, Legal, Communications, IR, Facilities, Events, and IT. Prior to joining Pharmacyclics, Inc., Ramses managed assets for US high net-worth equity investors and large European closed-end funds. In addition to co-founding several companies and serving on boards of directors, Ramses has also worked with Robert W. Duggan & Associates, providing analysis and due diligence that led to investments in several companies, including Pharmacyclics, Inc. Ramses began his career at Commerzbank AG in Germany, where he was an investment banker and portfolio manager for international clients. He earned the Diplom Kaufmann degree with distinction in Finance and Banking from the Westfaelische Wilhelms Universität of Muenster, Germany.


General Member

Jonathan is founder and CEO of The Trout Group, an investor relations firm in the life sciences industry. Jonathan also founded Trout Group’s sister company, Trout Capital LLC, in 2004 to assist clients in a financial advisory role. Prior to founding Trout in 1996, Jonathan was a sell-side analyst at a healthcare-focused investment bank. Before his career on Wall Street, Jonathan spent four years at DuPont Pharma in various sales and marketing positions. Jonathan holds a Bachelor of Science degree in biology and chemistry from The University of North Carolina – Chapel Hill and a Master of Business Administration degree in finance from New York University’s Stern School of Business. He also holds Series 7, 24, 79 and 63 securities licenses.




Lei Anderson

Executive Director, Investor Relations

Lei has over 20 years of cross border investment experience between the US and China. She is a founding partner of UTC Links, a M&A and boutique investment firm and is also the founder and CEO of Kerrgo who partners with Chinese and Israeli companies to invest in the life science and health care industry. 
Lei was born in Shanghai and received her undergraduate degree from Fudan University with a major in World Economics. In the late 80s she came to Montana State University for her graduate studies in Applied Economics. Lei started her early career working at Cathy Investment Inc. as a project manager to organize and negotiate with different government levels on infrastructure projects built and managed by Chinese and Western joint venture companies all over China. Later she headed Human Resources and the Public Relation Departments for Bass PLC – Asia, where she restructured and reengineered multi-billion RMB ventures to ensure a smooth integration between Asian and Western businesses.
Lei is also active in the following professional affiliations:
Experts Panel Committee at China Science and Technoloy Bureau
Information Manager of VC Taskforce Silicon Valley
MADE (Montana Academy of Distinguished Entrepreneurs) appointed by Dean of University of Montana
Bioscience Alliance of Montana
Active Member of the Chinese Overseas Organization and the member of entrepreneur’s sub-committee in both US and China


Privacy Policy    |    Terms of Use

Point Sur Investors LLC (PSI) is an independent, privately held investment advisor located in Palo Alto, California. The materials herein are intended solely for the recipient of the password and neither the materials nor the password may be transmitted to any other person without Point Sur Investors’ consent. This website is neither an offer to sell nor a solicitation of an offer to buy any security.


Copyright © 2015 Point Sur Investors LLC. All rights reserved.

926B Emerson St. Palo Alto, CA 94301 | Phone: 650-600-8302